Not sure if the market will like that cost guidance for FY19 at A$1350-1390/oz. Not a lot of capex outside of the sustaining spend so should still have decent cash flow.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025